Status:

RECRUITING

Diagnosis and Treatment of Leishmania Infections

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

Leishmaniasis

Skin Diseases, Parasitic

Eligibility:

All Genders

3-100 years

Brief Summary

This study will examine the natural history of Leishmanial infections and their treatments. It will provide an opportunity for NIAID staff to learn more about leishmaniasis and perhaps to improve diag...

Detailed Description

Patients admitted on this protocol will have, or be suspected of having, a Leishmania infection. The major objectives of the protocol are to diagnose and classify the Leishmania infection and to provi...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Individuals aged 3 to 100 years.
  • Diagnosis of leishmaniasis:
  • A: Biopsy proven
  • OR
  • B: Likely diagnosis of leishmaniasis based on :
  • Epidemiologic exposure, clinical manifestations, and time course
  • Willingness to allow samples to be stored for future research.
  • EXCLUSION CRITERIA:
  • Any condition that, in the judgment of the investigator, may put the participant at undue risk or make them unsuitable for participation in the study.

Exclusion

    Key Trial Info

    Start Date :

    November 30 2001

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    Estimated Enrollment :

    289 Patients enrolled

    Trial Details

    Trial ID

    NCT00344188

    Start Date

    November 30 2001

    Last Update

    January 8 2026

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center

    Bethesda, Maryland, United States, 20892